Sugi Predict

Sugi Predict / Compounds / SCHEMBL4243436

SCHEMBL4243436

SCHEMBL4243436

CC(OC(=O)C(N)c1ccccc1-c1ccccc1C(=O)NCCc1ccccn1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 6/20 0.57
▸ KCNA3 P22001 2/20 0.57
▸ KCNK3 O14649 1/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TAS1R3 Q7RTX0 1/20 0.40
▸ TAS1R1 Q7RTX1 1/20 0.40
▸ SCN9A Q15858 1/20 0.39
▸ TP53 P04637 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SORT1 Q99523 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451241 0.91 KCNA5 (0.68) KCNA5KCNA3KCNK3SMN1; SMN2NPC1
SCHEMBL2207911 0.83 KCNA5 (0.82) KCNA5KCNA3KCNK3SMN1; SMN2NPC1
SCHEMBL2207907 0.83 KCNA5 (0.82) KCNA5KCNA3KCNK3SMN1; SMN2NPC1
SCHEMBL2210715 0.83 KCNA5 (0.82) KCNA5KCNA3KCNK3SMN1; SMN2NPC1
SCHEMBL2211818 0.80 KCNA5 (0.49) KCNA5KCNA3KCNK3SMN1; SMN2NPC1
SCHEMBL5444524 0.78 KCNA5 (0.66) KCNA5KCNA3KCNK3SMN1; SMN2NPC1
SCHEMBL12434009 0.75 KCNA5 (0.79) KCNA5KCNA3KCNK3TAS1R3TAS1R1
SCHEMBL12434007 0.74 KCNA5 (0.75) KCNA5KCNA3KCNK3SMN1; SMN2TAS1R3
SCHEMBL498107 0.73 KCNA5 (1.00) KCNA5KCNA3KCNK3TAS1R3TAS1R1
SCHEMBL2212471 0.73 KCNA5 (1.00) KCNA5KCNA3KCNK3TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514582-B2 2′-substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-04-07 — — US disclosed
US-20040102513-A1 2'-Substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them AVENTIS PHARMA DEUTSCHLAND GMBH 2004-05-27 — — US disclosed
US-20030171351-A1 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them AVENTIS PHARMA DEUTSCHLAND GMBH 2003-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171351-A1 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them MLLT3, RYR2, KCNH1 KCNA5 104/4885KCNA3 107/4885KCNK3 396/4885
US-20040102513-A1 2'-Substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them MLLT3, RYR2, CACNA1E KCNA5 97/4885KCNA3 101/4885KCNK3 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.